APPLIED GENETIC TECHNOLOGIES CORP Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q3 2017 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Applied Genetic Technologies Corp quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q3 2017 to Q3 2022.
  • Applied Genetic Technologies Corp Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2022 was -$16M, a 0.63% decline year-over-year.
  • Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$65.7M, a 28.5% decline from 2021.
  • Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$51.2M, a 23% decline from 2020.
  • Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$41.6M, a 77.4% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$16M -$101K -0.63% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q3 2021 -$15.9M -$3.02M -23.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q3 2020 -$12.9M -$2.2M -20.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q3 2019 -$10.7M -$11.3M -1938% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q3 2018 $583K +$9.23M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q3 2017 -$8.65M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.